<p>文藝復興集團有限公司在最近向美國證券交易委員會提交的文件中披露，在第二季度將其在 Hims &amp; Hers Health, Inc. (NYSE:HIMS - 免費報告) 的持股增加了 99.0%。該公司在此期間額外購買了 87,755 股後，持有該公司 176,384 股股票。文藝復興集團有限公司在最近一個季度末持有的 Hims &amp; Hers Health 的股份約佔 0.08%，價值 8,793,000 美元。</p>
<p>獲取 <strong>Hims &amp; Hers Health</strong> 的提醒：</p>
<ul>
<li>為什麼 Hims &amp; Hers 股票在第三季度業績喜憂參半後可能值得購買</li>
</ul>
<p>其他一些對沖基金和機構投資者最近也調整了對該公司的持股。Nuveen LLC 在第一季度購買了 Hims &amp; Hers Health 的新股份，價值 58,403,000 美元。CloudAlpha Capital Management Limited Hong Kong 在第一季度購買了 Hims &amp; Hers Health 的新股份，價值 20,580,000 美元。密歇根州退休系統在第二季度將其在 Hims &amp; Hers Health 的持股增加了 84.9%。密歇根州退休系統現在持有該公司 1,379,100 股股票，價值 68,748,000 美元，此前在上個季度額外購買了 633,300 股。Jump Financial LLC 在第一季度將其在 Hims &amp; Hers Health 的持股增加了 633.2%。Jump Financial LLC 現在持有該公司 725,445 股股票，價值 21,437,000 美元，此前在上個季度額外購買了 626,496 股。最後，北方信託公司在第一季度將其在 Hims &amp; Hers Health 的持股增加了 19.5%。北方信託公司現在持有該公司 2,435,512 股股票，價值 71,969,000 美元，此前在上個季度額外購買了 397,310 股。目前，63.52% 的股票由機構投資者持有。</p>
<h2>Hims &amp; Hers Health 股票表現</h2>
<p>HIMS 的股票在週三開盤價為 36.36 美元。該公司的債務與股本比率為 1.67，速動比率為 1.64，流動比率為 1.88。該股票的 50 日移動平均線為 50.12 美元，200 日移動平均線為 51.42 美元。該股票的市值為 82.8 億美元，市盈率為 67.33，市盈增長比率為 7.08，貝塔係數為 2.20。Hims &amp; Hers Health, Inc. 的一年最低價為 20.02 美元，一年最高價為 72.98 美元。</p>
<ul>
<li>Hims &amp; Hers 的空頭頭寸接近歷史最高水平，是否值得抄底？</li>
</ul>
<p>Hims &amp; Hers Health (NYSE:HIMS - 獲取免費報告) 最近於 11 月 3 日星期一公佈了季度財報。該公司報告每股收益 (EPS) 為 0.06 美元，低於市場共識預期的 0.09 美元，差額為 0.03 美元。該公司在本季度的收入為 5.9898 億美元，而分析師預期為 5.7899 億美元。Hims &amp; Hers Health 的股本回報率為 24.67%，淨利潤率為 6.05%。該公司的季度收入較去年同期增長了 49.2%。在去年同期，該公司每股收益為 0.32 美元。Hims &amp; Hers Health 已設定 2025 財年的每股收益指導。2025 財年第四季度的指導為每股收益。整體來看，研究分析師預測 Hims &amp; Hers Health, Inc. 本年度將發佈 0.29 的每股收益。</p>
<p>Hims &amp; Hers Health 宣佈其董事會已於 11 月 17 日星期一批准了一項股票回購計劃，授權公司回購 2.5 億美元的流通股票。該回購授權允許公司通過公開市場購買最多 3% 的股票。股票回購計劃通常表明公司的管理層認為其股票被低估。</p>
<h2>Hims &amp; Hers Health 的內部買賣</h2>
<ul>
<li>3 只利用人工智能推動增長的醫療保健股票</li>
</ul>
<p>在 Hims &amp; Hers Health 的其他新聞中，內部人士 Soleil Boughton 於 11 月 10 日星期一出售了 2,637 股該公司的股票。股票以平均價格 42.53 美元出售，總價值為 112,151.61 美元。出售後，內部人士直接持有該公司 155,856 股股票，價值約 6,628,555.68 美元。這代表其持股減少了 1.66%。該交易已在向證券交易委員會提交的文件中披露，可以通過此鏈接訪問。此外，首席財務官 Oluyemi Okupe 於 10 月 17 日星期五出售了 11,592 股 Hims &amp; Hers Health 股票。股票以平均價格 57.13 美元出售，總價值為 662,250.96 美元。交易後，首席財務官持有該公司 70,232 股股票，價值 4,012,354.16 美元。該交易使其持股減少了 14.17%。該出售的披露信息可在證券交易委員會的文件中找到。在過去的九十天裏，內部人士出售了價值 31,837,916 美元的 584,209 股公司股票。公司內部人士持有該公司 17.71% 的股份。</p>
<h2>華爾街分析師的看法</h2>
<p>HIMS 最近成為幾份分析師報告的主題。Canaccord Genuity Group 在 9 月 12 日星期五的研究報告中重申了對 Hims &amp; Hers Health 股票的 &#34;買入&#34; 評級，並設定了 68.00 美元的目標價。Wall Street Zen 在 11 月 8 日星期六的報告中將 Hims &amp; Hers Health 的評級從 &#34;持有&#34; 下調至 &#34;賣出&#34;。BTIG Research 在 11 月 4 日星期二的研究報告中重新發布了 &#34;買入&#34; 評級，並對 Hims &amp; Hers Health 股票設定了 85.00 美元的目標價。Truist Financial 在 8 月 18 日星期一的研究報告中將 Hims &amp; Hers Health 的目標價從 48.00 美元下調至 37.00 美元，並對該股票設定了 &#34;持有&#34; 評級。最後，Needham &amp; Company LLC 在 8 月 5 日星期二的研究報告中重申了對 Hims &amp; Hers Health 股票的 &#34;持有&#34; 評級。兩位股票研究分析師對該股票給予了買入評級，十位分析師給予了持有評級，三位分析師給予了賣出評級。根據 MarketBeat 的數據，該股票的共識評級為 &#34;減持&#34;，共識目標價為 45.27 美元。</p>
<p><strong>閲讀我們關於 Hims &amp; Hers Health 的最新報告</strong></p>
<h2>Hims &amp; Hers Health 公司簡介</h2>
<p>(免費報告)</p>
<p>Hims &amp; Hers Health, Inc. 運營一個遠程醫療諮詢平台。它將消費者與醫療專業人士連接起來，使他們能夠獲得心理健康、性健康、皮膚科和初級護理的醫療服務。該公司成立於 2017 年，總部位於加利福尼亞州舊金山。</p>
<h2>另見</h2>
<ul>
<li>我們更看好的五隻股票，勝過 Hims &amp; Hers Health</li>
<li>如何找到財報電話會議記錄</li>
<li>美敦力股票找到立足點——現在正在獲得動能</li>
<li>如何投資保險公司：指南</li>
<li>感恩節餐桌上有什麼？每道菜的股票推薦</li>
<li>股息篩選器：如何在購買前評估股息股票</li>
<li>為什麼家得寶的痛苦可能是長期投資者的收益</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhJTVM?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhJTVM"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 $1,000 在 Hims &amp; Hers Health 嗎？</h2>
<p>在你考慮 Hims &amp; Hers Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已確定五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前立即購買……而 Hims &amp; Hers Health 並不在名單上。</p>
<p>雖然 Hims &amp; Hers Health 目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

HIMS

<p>Renaissance Group LLC 在第二季度將其在 Hims & Hers Health, Inc. 的持股增加了 99%，額外購買了 87,755 股，總計持有 176,384 股，價值 879 萬美元。機構投資者目前持有該股票的 63.52%。Hims & Hers Health 報告第三季度每股收益為 0.06 美元，未達到預期，收入同比增長 49.2%。該公司宣佈了一項 2.5 億美元的股票回購計劃，表明其可能被低估。近期還報告了內部人士的銷售情況</p>

<p>Renaissance Group LLC lifted its holdings in Hims &amp; Hers Health, Inc. (NYSE:HIMS - Free Report) by 99.0% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 176,384 shares of the company's stock after purchasing an additional 87,755 shares during the period. Renaissance Group LLC owned about 0.08% of Hims &amp; Hers Health worth $8,793,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>文藝復興集團有限公司在最近向美國證券交易委員會提交的文件中披露，在第二季度將其在 Hims &amp; Hers Health, Inc. (NYSE:HIMS - 免費報告) 的持股增加了 99.0%。該公司在此期間額外購買了 87,755 股後，持有該公司 176,384 股股票。文藝復興集團有限公司在最近一個季度末持有的 Hims &amp; Hers Health 的股份約佔 0.08%，價值 8,793,000 美元。</p>
</div><p>Get <strong>Hims &amp; Hers Health</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Hims &amp; Hers Health</strong> 的提醒：</p>
</div><ul>
<li>Why Hims &amp; Hers Stock May Be a Buy After Mixed Q3 Results</li>
</ul>
<div class="lb-trans"><ul>
<li>為什麼 Hims &amp; Hers 股票在第三季度業績喜憂參半後可能值得購買</li>
</ul>
</div><p>A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Nuveen LLC purchased a new stake in Hims &amp; Hers Health during the first quarter worth $58,403,000. CloudAlpha Capital Management Limited Hong Kong purchased a new stake in shares of Hims &amp; Hers Health during the 1st quarter worth $20,580,000. State of Michigan Retirement System grew its stake in Hims &amp; Hers Health by 84.9% in the second quarter. State of Michigan Retirement System now owns 1,379,100 shares of the company's stock valued at $68,748,000 after purchasing an additional 633,300 shares during the last quarter. Jump Financial LLC raised its holdings in Hims &amp; Hers Health by 633.2% in the first quarter. Jump Financial LLC now owns 725,445 shares of the company's stock worth $21,437,000 after purchasing an additional 626,496 shares in the last quarter. Finally, Northern Trust Corp lifted its position in shares of Hims &amp; Hers Health by 19.5% during the first quarter. Northern Trust Corp now owns 2,435,512 shares of the company's stock valued at $71,969,000 after buying an additional 397,310 shares during the last quarter. 63.52% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他一些對沖基金和機構投資者最近也調整了對該公司的持股。Nuveen LLC 在第一季度購買了 Hims &amp; Hers Health 的新股份，價值 58,403,000 美元。CloudAlpha Capital Management Limited Hong Kong 在第一季度購買了 Hims &amp; Hers Health 的新股份，價值 20,580,000 美元。密歇根州退休系統在第二季度將其在 Hims &amp; Hers Health 的持股增加了 84.9%。密歇根州退休系統現在持有該公司 1,379,100 股股票，價值 68,748,000 美元，此前在上個季度額外購買了 633,300 股。Jump Financial LLC 在第一季度將其在 Hims &amp; Hers Health 的持股增加了 633.2%。Jump Financial LLC 現在持有該公司 725,445 股股票，價值 21,437,000 美元，此前在上個季度額外購買了 626,496 股。最後，北方信託公司在第一季度將其在 Hims &amp; Hers Health 的持股增加了 19.5%。北方信託公司現在持有該公司 2,435,512 股股票，價值 71,969,000 美元，此前在上個季度額外購買了 397,310 股。目前，63.52% 的股票由機構投資者持有。</p>
</div><h2>Hims &amp; Hers Health Stock Performance</h2>
<div class="lb-trans"><h2>Hims &amp; Hers Health 股票表現</h2>
</div><p>Shares of HIMS opened at $36.36 on Wednesday. The company has a debt-to-equity ratio of 1.67, a quick ratio of 1.64 and a current ratio of 1.88. The stock has a 50-day moving average of $50.12 and a two-hundred day moving average of $51.42. The stock has a market cap of $8.28 billion, a P/E ratio of 67.33, a P/E/G ratio of 7.08 and a beta of 2.20. Hims &amp; Hers Health, Inc. has a one year low of $20.02 and a one year high of $72.98.</p>
<div class="lb-trans"><p>HIMS 的股票在週三開盤價為 36.36 美元。該公司的債務與股本比率為 1.67，速動比率為 1.64，流動比率為 1.88。該股票的 50 日移動平均線為 50.12 美元，200 日移動平均線為 51.42 美元。該股票的市值為 82.8 億美元，市盈率為 67.33，市盈增長比率為 7.08，貝塔係數為 2.20。Hims &amp; Hers Health, Inc. 的一年最低價為 20.02 美元，一年最高價為 72.98 美元。</p>
</div><ul>
<li>Hims &amp; Hers Short Interest Nears All-Time High, Buy The Dip?</li>
</ul>
<div class="lb-trans"><ul>
<li>Hims &amp; Hers 的空頭頭寸接近歷史最高水平，是否值得抄底？</li>
</ul>
</div><p>Hims &amp; Hers Health (NYSE:HIMS - Get Free Report) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.03). The firm had revenue of $598.98 million during the quarter, compared to analysts' expectations of $578.99 million. Hims &amp; Hers Health had a return on equity of 24.67% and a net margin of 6.05%.The company's revenue for the quarter was up 49.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.32 earnings per share. Hims &amp; Hers Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. As a group, research analysts predict that Hims &amp; Hers Health, Inc. will post 0.29 EPS for the current year.</p>
<div class="lb-trans"><p>Hims &amp; Hers Health (NYSE:HIMS - 獲取免費報告) 最近於 11 月 3 日星期一公佈了季度財報。該公司報告每股收益 (EPS) 為 0.06 美元，低於市場共識預期的 0.09 美元，差額為 0.03 美元。該公司在本季度的收入為 5.9898 億美元，而分析師預期為 5.7899 億美元。Hims &amp; Hers Health 的股本回報率為 24.67%，淨利潤率為 6.05%。該公司的季度收入較去年同期增長了 49.2%。在去年同期，該公司每股收益為 0.32 美元。Hims &amp; Hers Health 已設定 2025 財年的每股收益指導。2025 財年第四季度的指導為每股收益。整體來看，研究分析師預測 Hims &amp; Hers Health, Inc. 本年度將發佈 0.29 的每股收益。</p>
</div><p>Hims &amp; Hers Health announced that its board has approved a stock buyback program on Monday, November 17th that authorizes the company to repurchase $250.00 million in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 3% of its stock through open market purchases. Stock repurchase programs are often an indication that the company's management believes its stock is undervalued.</p>
<div class="lb-trans"><p>Hims &amp; Hers Health 宣佈其董事會已於 11 月 17 日星期一批准了一項股票回購計劃，授權公司回購 2.5 億美元的流通股票。該回購授權允許公司通過公開市場購買最多 3% 的股票。股票回購計劃通常表明公司的管理層認為其股票被低估。</p>
</div><h2>Insider Buying and Selling at Hims &amp; Hers Health</h2>
<div class="lb-trans"><h2>Hims &amp; Hers Health 的內部買賣</h2>
</div><ul>
<li>3 Healthcare Stocks Using AI to Drive Growth</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只利用人工智能推動增長的醫療保健股票</li>
</ul>
</div><p>In other Hims &amp; Hers Health news, insider Soleil Boughton sold 2,637 shares of the company's stock in a transaction on Monday, November 10th. The shares were sold at an average price of $42.53, for a total value of $112,151.61. Following the sale, the insider directly owned 155,856 shares of the company's stock, valued at approximately $6,628,555.68. This represents a 1.66% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through this link. Also, CFO Oluyemi Okupe sold 11,592 shares of Hims &amp; Hers Health stock in a transaction dated Friday, October 17th. The shares were sold at an average price of $57.13, for a total value of $662,250.96. Following the transaction, the chief financial officer owned 70,232 shares of the company's stock, valued at $4,012,354.16. The trade was a 14.17% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 584,209 shares of company stock worth $31,837,916. Company insiders own 17.71% of the company's stock.</p>
<div class="lb-trans"><p>在 Hims &amp; Hers Health 的其他新聞中，內部人士 Soleil Boughton 於 11 月 10 日星期一出售了 2,637 股該公司的股票。股票以平均價格 42.53 美元出售，總價值為 112,151.61 美元。出售後，內部人士直接持有該公司 155,856 股股票，價值約 6,628,555.68 美元。這代表其持股減少了 1.66%。該交易已在向證券交易委員會提交的文件中披露，可以通過此鏈接訪問。此外，首席財務官 Oluyemi Okupe 於 10 月 17 日星期五出售了 11,592 股 Hims &amp; Hers Health 股票。股票以平均價格 57.13 美元出售，總價值為 662,250.96 美元。交易後，首席財務官持有該公司 70,232 股股票，價值 4,012,354.16 美元。該交易使其持股減少了 14.17%。該出售的披露信息可在證券交易委員會的文件中找到。在過去的九十天裏，內部人士出售了價值 31,837,916 美元的 584,209 股公司股票。公司內部人士持有該公司 17.71% 的股份。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師的看法</h2>
</div><p>HIMS has been the subject of several recent analyst reports. Canaccord Genuity Group reiterated a &#34;buy&#34; rating and set a $68.00 price objective on shares of Hims &amp; Hers Health in a research note on Friday, September 12th. Wall Street Zen lowered Hims &amp; Hers Health from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a report on Saturday, November 8th. BTIG Research reissued a &#34;buy&#34; rating and issued a $85.00 price objective on shares of Hims &amp; Hers Health in a research report on Tuesday, November 4th. Truist Financial dropped their target price on Hims &amp; Hers Health from $48.00 to $37.00 and set a &#34;hold&#34; rating on the stock in a research note on Monday, August 18th. Finally, Needham &amp; Company LLC reaffirmed a &#34;hold&#34; rating on shares of Hims &amp; Hers Health in a research report on Tuesday, August 5th. Two equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of &#34;Reduce&#34; and a consensus price target of $45.27.</p>
<div class="lb-trans"><p>HIMS 最近成為幾份分析師報告的主題。Canaccord Genuity Group 在 9 月 12 日星期五的研究報告中重申了對 Hims &amp; Hers Health 股票的 &#34;買入&#34; 評級，並設定了 68.00 美元的目標價。Wall Street Zen 在 11 月 8 日星期六的報告中將 Hims &amp; Hers Health 的評級從 &#34;持有&#34; 下調至 &#34;賣出&#34;。BTIG Research 在 11 月 4 日星期二的研究報告中重新發布了 &#34;買入&#34; 評級，並對 Hims &amp; Hers Health 股票設定了 85.00 美元的目標價。Truist Financial 在 8 月 18 日星期一的研究報告中將 Hims &amp; Hers Health 的目標價從 48.00 美元下調至 37.00 美元，並對該股票設定了 &#34;持有&#34; 評級。最後，Needham &amp; Company LLC 在 8 月 5 日星期二的研究報告中重申了對 Hims &amp; Hers Health 股票的 &#34;持有&#34; 評級。兩位股票研究分析師對該股票給予了買入評級，十位分析師給予了持有評級，三位分析師給予了賣出評級。根據 MarketBeat 的數據，該股票的共識評級為 &#34;減持&#34;，共識目標價為 45.27 美元。</p>
</div><p><strong>Read Our Latest Report on Hims &amp; Hers Health</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 Hims &amp; Hers Health 的最新報告</strong></p>
</div><h2>Hims &amp; Hers Health Company Profile</h2>
<div class="lb-trans"><h2>Hims &amp; Hers Health 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>Hims &amp; Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.</p>
<div class="lb-trans"><p>Hims &amp; Hers Health, Inc. 運營一個遠程醫療諮詢平台。它將消費者與醫療專業人士連接起來，使他們能夠獲得心理健康、性健康、皮膚科和初級護理的醫療服務。該公司成立於 2017 年，總部位於加利福尼亞州舊金山。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Hims &amp; Hers Health</li>
<li>Where to Find Earnings Call Transcripts</li>
<li>Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum</li>
<li>How to Invest in Insurance Companies: A Guide</li>
<li>What’s on the Thanksgiving Table? A Stock Pick for Every Course</li>
<li>Dividend Screener: How to Evaluate Dividend Stocks Before Buying</li>
<li>Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，勝過 Hims &amp; Hers Health</li>
<li>如何找到財報電話會議記錄</li>
<li>美敦力股票找到立足點——現在正在獲得動能</li>
<li>如何投資保險公司：指南</li>
<li>感恩節餐桌上有什麼？每道菜的股票推薦</li>
<li>股息篩選器：如何在購買前評估股息股票</li>
<li>為什麼家得寶的痛苦可能是長期投資者的收益</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhJTVM" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=HIMS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Hims &amp; Hers Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 $1,000 在 Hims &amp; Hers Health 嗎？</h2>
</div><p>Before you consider Hims &amp; Hers Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Hims &amp; Hers Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hims &amp; Hers Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已確定五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前立即購買……而 Hims &amp; Hers Health 並不在名單上。</p>
</div><p>While Hims &amp; Hers Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Hims &amp; Hers Health 目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Renaissance Group LLC 收購了 Hims & Hers Health, Inc. 的 87,755 股股票 $HIMS